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Calendula oﬃcinalis is an annual herb from Mediterranean origin which is popularly used in wound healing and as an anti-
inﬂammatory agent. In this study, the ethanolic extract, the dichloromethane, and hexanic fractions of the ﬂowers from plants
growing in Brazil were produced. The angiogenic activity of the extract and fractions was evaluated through the chorioallantoic
membrane and cutaneous wounds in rat models. The healing activity of the extract was evaluated by the same cutaneous wounds
model through macroscopic, morphometric, histopathologic, and immunohistochemical analysis. The antibacterial activity of
the extract and fractions was also evaluated. This experimental study revealed that C. oﬃcinalis presented anti-inﬂammatory
and antibacterial activities as well as angiogenic and ﬁbroplastic properties acting in a positive way on the inﬂammatory and
proliferative phases of the healing process.
1.Introduction
Calendula oﬃcinalis L. (Compositae) is an annual herb
from Mediterranean origin. It is believed that it has been
introduced in England during the 13th century [1]a n d
found in Europe as a cultured plant. Wild plants are rare
[2]. Its medicinal use seemed to be most diﬀused from the
13th century and especially in the wound healing aspect.
It was used as balm and creams, as antiseptic and anti-
inﬂammatory agents during the north-American civil war as
well as in the ﬁrst World War [2, 3].
The ﬂowers of C. oﬃcinalis are found in chapters which
may distinguish the varieties through its color and size.
They have medicinal use especially as an anti-inﬂammatory
agent, for the treatment of wound, ﬁrst-degree burns,
contusions,andskinrashes.TheGermansanitaryauthorities
recommended its topic use in leg ulcers and its internal use
only against inﬂammatory lesions in the oral and pharynx
mucosae[4–6].Themainchemicalcomponentsfoundinthe
ﬂowers are saponins, triterpenes, alcohol triterpenes, fatty
acid esters, carotenoids, ﬂavonoids, coumarines, essential
oils, hydrocarbons, and fatty acids [7–9].
The anti-inﬂammatory activity of C. oﬃcinalis ﬂowers
cultured in Europe and Asia has been evaluated and evi-
denced through the model of edema induction of the ear
through croton oil and the model of edema induction of the
paw through carrageenan [2, 3, 7, 10–12]. The angiogenic
activity of the aqueous extract of C. oﬃcinalis cultured in
England was also evidenced [13].
Most of the literatures that report the medicinal activity
of C. oﬃcinalis were performed in European or Asian coun-
tries from plants cultured in those locations. The diﬀerent
conditions of culturing a plant may alter some speciﬁc
patterns of the vegetal metabolism which may activate or
inactivate some metabolic pathways [14]. This study aimed
at the evaluation of the wound healing and antibacterial2 Evidence-Based Complementary and Alternative Medicine
activities of the ethanolic extract and its fractions from the
ﬂowers of C. oﬃcinalis cultured in Brazil (Parana estate).
2.MaterialandMethods
2.1. Plant Material. Dried and pulverized ﬂowers of C.
oﬃcinaliscollectedinParanaestate,Brazil,during themonth
of February, 2006, were commercially obtained from the
company Empresa Cloroﬁla (Goiania, GO, Brazil). To the
quality control of the plant material, a pharmacognostic
evaluation was performed which analyzed the organoleptic
properties, ashes microscopy, and the ashes contents. Also
the total ﬂavonoids content dosages and thin-layer chro-
matography analysis were performed [3, 15].
To obtain the ethanolic extract (CEE), the pulverized
ﬂowers were extracted with 96◦ GL PA ethanol by cold
maceration and concentrated by rotary evaporator at 40◦C.
To obtain of the hexanic and dichloromethane fractions, the
CEE was soluble into a MeOH/H2O (7:1) mix followed by
an extraction with hexane and afterwards with dichloro-
methane. The resulting extracts which were hexanic (HCF)
and dichloromethane (DCF) were concentrated by rotary
evaporator at 40◦C.
As the ethanolic extract, the hexanic and dichlorometh-
ane fractions were insoluble in distilled water, solutions of
1% of the extract and fractions previously diluted in 70%
ethanol were prepared and then used to test the angiogenic
activity of the CAM. To test the angiogenic activity of the
ethanolic extract on cutaneous wounds in rats, an aqueous
solution of 1% of the extract was daily prepared.
2.2. Experimental Animals. 36 Wistar female rats, 60 days
old, weighing between 160 and 190g-interval were used.
The animals were adapted during a ten-day period and
maintained in individual polyethylene cages covered with
coarse saw dust under controlled environmental conditions
such as room temperature of 23 ± 2◦C, relative air humidity
between 50 and 70%, and photoperiod light/dark of 12h.
Water and ration were supplied ad libitum.
75 fertilized eggs from Cobb chickens, two days old, were
used and obtained from matrixes with age varying from 34
to 35 weeks old. We followed the ethical principles in animal
experimentation recommended by the National Council for
Control of Animal for Experiments (CONCEA).
The experimental protocol of the animals used in this
study was evaluated and approved by the Ethics in Research
Committee of the Federal University of Goias (protocol
number 019/2007).
2.3. Chorioallantoic Membrane Model (CAM)
2.3.1. Preparation of the CAM. The CAM was prepared aim-
ing the angiogenic activity evaluation according to an
adapted methodology [16] .T h ee g g sw e r er a n d o m l yd i s -
tributed into four groups with 15 eggs each and submitted
to the following treatments: SC1: solvent control 1 (70%
ethanol); PC: positive control at 1% (17 β-estradiol);
SC2: solvent control 2 (distilled water); CEE: ethanolic
extract at 1%; DCF: dichloromethane fraction at 1%; HCF:
hexanic fraction at 1%.
According to previously established protocols [16], the
opening of the egg shell, the removal of the albumen, and the
treatments were performed inside a type II security biologi-
cal chamber. On the third day of incubation, through a small
opening of the egg shell, 2 to 3mL of albumen were removed
followedbythesealingoftheoriﬁcewithhistologicalparaﬃn
in fusion point. The incubation continued until the 10th
day when the eggs were treated with 0.1mL of the solutions
described above which were instilled above the CAM surface.
The eggs were sealed again and then incubated for two days.
After the euthanasia of the embryos, through medullar
section of the atlantoocciptal region, fragments of the CAM
from each egg were collected to morphometric analysis and
quantiﬁcation of the blood vessels.
2.3.2. Morphometric Evaluation of the CAM. To the morpho-
metricevaluationoftheCAM,afreshfragmentwascollected
from 10 eggs from each group and distended on a glass slide
and microscopically analyzed.
The microscopical analysis was performed with a digital
image analysis system. The percentage of the vascular area
per ﬁeld was calculated through the Image J 1.3.1 (NIH,
USA) software. 30 random ﬁelds were photographed and
analyzed per sample, and this number was determined by
accumulated mean [17].
2.3.3. Evaluation of the Inﬂammatory Cells and the Number
of Blood Vessels in the CAM. The membranes were ﬁxed
in tamponated formalin, processed and blocked into paraf-
ﬁn, and then sectioned into 5 micrometer sections and
stained with hematoxylin and eosin (HE). 20 randomly
chosen ﬁelds were photographed, number determined by
accumulated mean. The inﬂammatory cells found in the
CAM were classiﬁed in a qualitative form into absent
(0/3), discrete (1/3), moderate (2/3), and accentuated
(3/3).
The counting of the blood vessels in mesoderm from
the CAM was performed through planimetry by counting
of the points by using the GIM; P 2.4.3 software. A square
reticulum composed by 25 points was overlapped on top of
the histologic image [18, 19].
2.4. Cutaneous Wounds in Rats Model. The animals were
weighted and randomly divided in two groups (n = 18)
a n ds u b d i v i d e di nt h r e es u b g r o u p s( n = 6). The groups
were evaluated in determined moments of the postoperatory
(PO) period according to the protocol previously established
by Lopes et al. [20]a n dG a r r o se ta l .[ 21] aiming of
the evaluation of the initial phases of the inﬂammatory
process (4 and 7 PO days) and the proliferative phase of the
inﬂammatory process (14 PO days) resulting in a general
evaluation of the healing. The groups are namely:
Group 1. Control (C), animals were treated with distilled
water. C1 was evaluated in the 4th PO day, C2 in the 7th PO
day, and C3 in the 14th PO day.Evidence-Based Complementary and Alternative Medicine 3
Group 2. CEE, animals were treated with aqueous solution
of the ethanolic extract at 1%. CEE1 evaluated in the 4th PO
day, CEE2 in the 7th PO day and CEE3 in the 14th PO day.
To the wound induction, a circular methalic punch of
1cm of diameter was used on the dorsocervical region of
each animal. The anesthetics consisted of the association
between ketamin (70mg/Kg, IM) and xylazine (10mg/Kg,
IM). Right after the surgery and daily afterwards on the same
hour, 100μL of the CEE solution and of the solvent (distilled
water) were instilled on the animals wounds.
Each animal was daily examined as to their general
aspect, and the macroscopic evaluation of the wound was
performed. The animals were euthanized in a CO2 chamber
at 4, 7, and 14 PO days accordingly to previous protocols
by Lopes et al. [20]a n dG a r r o se ta l .[ 21]. Fragments of the
cutaneous wounds were collected to the histopathologic and
immunohistochemical analysis.
2.4.1. Histopathologic and Morphometric Evaluation. The
morphometric analysis of the wounds was performed
through the photographed images of the wounds at days
zero, 4, 7, and 14 PO aiming of the determination of the
contraction of the wound area [22].
The histopathologic analysis was performed after the
fragments of the wounds were ﬁxed with 10% buﬀered
formalin, processed, and blocked with paraﬃn, and then
sectioned into 5 micrometer sections and stained with
hematoxylin and eosin (HE). The sections were also
stained with Picrossirius to the collagen quantiﬁcation
under polarized light [23] through the calculus of the
percentage of the marked area in green or reddish-yellow
by ﬁeld by using the IMAGE J 1.3.1 (NIH, USA) soft-
ware.
The histopathologic analysis at 4, 7, and 14 PO days
determined the healing phases of the wound through histo-
logic variables such as the presence of ﬁbrin, hemorrhage,
hyperemia, inﬂammatory inﬁltration, reepithelialization,
and epithelial hyperplasia [24].
2.4.2. Angiogenic Activity Evaluation through Immunohis-
tochemistry. Sections were incubated with bovine serum
albumin (BSA), the blockage of endogenous peroxidase was
performed,andthesectionswereincubatedwiththevascular
endothelial growth factor (VEGF) primary antibody (147)
(Santa Cruz Biotechnology-507), 1:500 dilution in a wet
chamber, overnight at 4◦C.
After this step, the streptavidin-biotin-peroxidase com-
plex (kit LSAB-Dako K0690) was instilled over the sections
for 20 minutes each reaction in a wet chamber at room tem-
perature. The reaction was revealed with diaminobenzidine
(DAB) solution, for 1 minute. A PBS solution was used for
washing between the steps. The sections were counterstained





endothelial cells was evaluated.
2.5. In Vitro Antibacterial Activity. To determine the
minimum inhibitory concentration (MIC), the cultures of
Staphylococcus aureus (ATCC 6532), Staphylococcus aureus
(ATCC 13048), Micrococcus roseus (ATCC 1740), Micrococcus
luteus (ATCC 9341), Bacillus cereus (ATCC 14576), Bacillus
stearothermophylus (ATCC 1262), Enterobacter cloacae
(HMA/FTA 502), Enterobacter aerogenes (ATCC 13048), Es-
cherichiacoli(ATCC25922),Pseudomonasaeruginosa(ATCC
9027), and Serratia marcescens (ATCC 14756) were used
through the plaque assay method. The microorganisms were
reactivated and processed according to NCCLS [25].
The MIC was determined through the plaque assay
method when 1000mg of the CEE, 500mg of the HCF,
and 350mg of the DHC were incubated in essay tubes with
1.0mL of DMSO.
2.6. Statistical Analysis. The results were submitted to the
statistical analysis through the GraphPad InStat programme
(Version3.05 forWindows). FromtheKolmogorov-Smirnov
normality test, the morphometric data from the CAM were
evaluated through the Kruskal-Wallis test followed by the
Dunn posttest. The counting of the blood vessels was ana-
lyzedthroughANOVAandtheTukeytest.Thehistopatologic
and immunohistochemical variables were analyzed through
the Mann-Whitney test. The signiﬁcance level was of P<
0.05.
3. Results and Discussion
The pulverized ﬂowers of C. oﬃcinalis presented a yellowish
coloring and soft and mildly aromatic odor. The microscopic
analysis of the dust through the Steinmetz and Etzold stain-
ing evidence its structures: biseriate multicellular trichome
of the corolla tube from the ligulate ﬂower, ligule epidermal
with striated cuticle and ligule parenchyma containing
droplets of oil and pollen grains.
The total content of the ashes was of 8.47%. The thin
layer chromatography evidenced the presence of rutin (Rf-
0.47), ﬂavonoids (Rf-0.29), and aglycone ﬂavonoids (Rf-
0.92). The contents of total ﬂavonoids from the pulverized
ﬂowers were of 0.77% and in the CEE of 1.29%. WHO
monographs [3] describe that C. oﬃcinalis should not
present less than 0.4% of total ﬂavonoids calculated as
hyperoside up until 10% of the total ashes.
All data obtained from the pharmacognostic analysis are
in accordance to what is described in the literature [3, 15]
which indicates that the plant material tested corresponded
to the pulverized ﬂowers of C. oﬃcinalis.
The evaluation of the angiogenic activity in the CAM
showed through the morphometric analysis an increase in
the vascular area in the positive control, ethanolic extract,
dichloromethane fraction, and hexane fraction groups when
compared to the solvent control 1 (Table 1).
The quantiﬁcation of the blood vessels performed
through planimetry of the CAM stained with H&E and
treated with positive control, ethanolic extract, dichlo-
ro-meth-ane fraction, and hexane fraction evidenced an
increase in the number of blood vessels when compared to
the solvent control 1 group (Table 2).4 Evidence-Based Complementary and Alternative Medicine
Table 1: Morphometry (median, minimum/maximum) of the
blood vessels from the fresh chorioallantoic membrane from
fertilized chicken eggs.







CAM: chorioallantoic membrane, CEE: ethanolic extract of ﬂowers
from Calendula oﬃcinalis at 1%, HCF: hexanic fraction at 1%, DCF:
dichloromethanefractionat1%,PC:positivecontrolat1%(17 β-estradiol),
SC1: solvent control with 70% ethanol, SC2: solvent control with distilled
water. ∗P<0.05 when compared to SC1.
When substances are administered on the surface of the
CAM, they may induce nonspeciﬁc inﬂammatory reactions
leading to a secondary vessel proliferative response [26]. In
this study, the CAM treated with C. oﬃcinalisin its extract or
fractionformspresentedadiscreteinﬂammatoryinﬁltration.
We may infer that the increase in the neovascularization
observed in the CAM is due to the direct acting of the
C. oﬃcinalis and its fractions and is not related to the
inﬂammatory reaction which is in accordance to similar
ﬁndings by Patrick et al. [13]. Although there are reports in
the literature [13] concerning the angiogenic activity of C.
oﬃcinalis, there were not found descriptions of which of its
component is responsible for this speciﬁc activity.
In the evaluation of the wound healing activity of
C. oﬃcinalis, only the ethanolic extract was used because
the extract and the fractions presented similar angiogenic
properties.
The macroscopic evaluation of the wounds did not show
purulent exudate in any of the wounded animals, but it was
possible to observe a serous exudation in the animals from
the CEE group up until the 4th PO day and in the control
group up until the 7th PO day. The crusts started to form
from the 3rd day, and, in the CEE group, they presented
thinner and wetter when compared to the control group
which were thicker and drier. At the 7th PO day, the crusts
began to detach showing signs of epithelialization of the
wounds, and, in the 14th PO day, the complete healing was
veriﬁed on both groups.
The microscopic evaluation of the CEE group at 4 and 7
PO days showed a signiﬁcant decrease as to the presence of
ﬁbrin (median = 1.0 and 2.0, resp.)and hyperemia (median
= 1.0 and 1.5, resp.) when compared to the control group at
thesamePOdays(median =3.0and2.5,resp.)(Figure 1).As
to the evaluation of the other variables such as hemorrhage,
inﬂammatory inﬁltration, reepithelialization, and epithelial
hyperplasia, there was not a signiﬁcant diﬀerence found
between the analyzed groups.
Previous studies evaluated and evidenced the anti-
inﬂammatory activity of C. oﬃcinalisand related this activity
to the presence of triterpenes, especially to faradiol esters
and taraxasterol [2, 3, 7, 10–12]. In this study, the same
eﬀect was evidenced due to the observation of the signiﬁcant
Table 2: Inﬂuence of the Calendula oﬃcinalis extract and fractions
on the number of blood vessels (median, minimum/maximum) of
the chorioallantoic membrane from fertilized chicken eggs.







CEE: ethanolic extract of ﬂowers from Calendula oﬃcinalis at 1%, HCF:
hexanic fraction at 1%, DCF: dichloromethane fraction at 1%, PC: positive
control at 1% (17 β-estradiol), SC1: solvent control with 70% ethanol, SC2:
solvent control with distilled water. ∗P<0.05 when compared to SC1.
diﬀerence of the presence of ﬁbrin and hyperemia found
which represents the circulatory alterations directly related
to the inﬂammatory phase of the healing process.
It was possible to observe a signiﬁcant increase in
the collagen amount in the CEE group at 4 and 7 PO
days (median = 8.27 and 6.33, resp.) when compared to
the control group (median = 5.33 and 4.31, resp.) which
indicates ﬁbroplasia (Figure 2) .O nt h e4 t hP Od a y ,i tw a s
possible to observe the brilliant green coloration of the
collagenonbothgroups,and,onthe7thPOday,thereddish-
yellow one especially on the CEE group.
There are no reports found in the literature on the colla-
gen mensuration through Picrossirius staining of cutaneous
wounds treated with C. oﬃcinalis.In this study, the statistical
conﬁrmation of the increase in the collagen concentration
in the wounds treated with the CEE at 4 and 7 PO days
indicates that the extract contributed to the greater synthesis
ofthisﬁber.Thisindicatesapositiveroleoftheextractonthe
cutaneous wounds healing process. The triterpene faradiol
palmitic ester stimulated the proliferation and migration
of ﬁbroblasts in previous in vitro studies [27]; we believe
that this may have occurred in our study, stimulating the
ﬁbroplasias evidenced here.
The immunohistochemical evaluation showed an
increase in the number of blood vessels in the dermis of the
rats treated with CEE as it had a positive marking for VEGF
(Figure 3). This ﬁnding conﬁrms the intense activity of the
extract on the neovascularization also observed on the CAM
model.
The immunohistochemistry technique is a viable tool
to angiogenesis evaluation through VEGF marking in this
experimental model. Our data indicated that the CEE
angiogenic property is not directly related to the increase
of the intensity of expression of this marker. Other pro-
aniogenic factors such as ﬁbroblast growth factor (FGF),
angiogenic cytokines as interleukin 8 (IL-8), tumor necrosis
factor-alfa (TNF-α), and transformation growth factor-beta
(TGF-β)[ 28, 29] may be related to the angiogenic activity
evidenced in the C. oﬃcinalis extract by this study.
The antibacterial activity of the CEE and the hexanic
fraction was observed against Gram-positive bacteria, and
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Figure 1: Photomicrograph of cutaneous wounds in rats at 4 (a1, a2) and 7 (b1, b2) PO days highlighting the presence of ﬁbrin (Fb). (a1)









Figure 2: Photomicrograph of the cutaneous wound in rats (n = 6) at 4 (a1, a2) and 7 (b1, b2) PO days. (a1) Control group, treated
with distilled water, type III collagen production evidenced through green polarized light; (a2) CEE group, type III collagen intense
production; (b1) control group, type I collagen production evidenced by orange-yellow polarized light; (b2) CEE group, intense type I




Figure 3: Photomicrograph from the dermis of rats at 7th PO days
(n = 6). (a) Solvent control with distilled water. (b) EEC at 1%.
Arrows indicate the VEGF positive marking on the dermis from
both groups. Immunohistochemistry, 400x.
The lowest concentrations of the extracts that inhibit micro-
organism’s growth were CEE, MIC of 0.39mg/mL against
S. aureus 13048 and B. stearo thermophylus;F D C ,M I Co f
4.37mg/mL against S. aureus 6532 and S. aureus 13048,
MIC of 1.08mg/mL against B. stearo thermophylus and B.
cereus, MIC of 0.5mg/mL against M. roseus; FHC, MIC of
0.19mg/mL against S. aureus 13048. According to Alonso
[2], the antibacterial activity is due to the presence of
ﬂavonoids and essential oils in C. oﬃcinalis.
In the case of wound contaminations, there is the for-
mation of a great quantity of exudate and toxin productions
which may retard the healing process [30] in addition to the
riskofpresentinganentrancepathwaytosystemicinfections.
The antibacterial activity of C. oﬃcinalis evidenced in this
study corroborates with the healing activity detected by this
plant in this study as it prevents secondary infections of the
wounds that can aggravate the injury.
4. Conclusions
Calendula oﬃcinalisgrowing in Brazil presented anti-inﬂam-
matory and antibacterial activities as well as the capability
of stimulating ﬁbroplasia and angiogenesis. Therefore, the C.
oﬃcinalis extracts act in a positive form on the inﬂammatory
and proliferative phases of the healing process of cutaneous
wounds.
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